Pharmaceutical Technology's In the Lab eNewsletter, October 2021

October 06, 2021

Having intelligent analytical tools can advance the detection of unknown impurities, which is important for ensuring small-molecule ingredient purity.

October 04, 2021

The expansion to SGS’s Poitiers facility in France is expected to improve the company’s drug development capabilities.

September 30, 2021

In September, Codex DNA released a full-length synthetic genome for the SARS-CoV-2 delta variant, which may accelerate discovery and development of diagnostics and treatments for COVID-19.

September 30, 2021

The new LabVantage Enterprise SaaS adds full configurability and custom interfacing capabilities.

September 30, 2021

Gyros’ new titer kit identifies adeno-associated virus serotype 9 in vector-based cell and gene therapy manufacturing.

September 29, 2021

USP is publishing the analytics-focused chapter, which considers validation activities, in advance of the official publication.

September 29, 2021

CuriRx’s CuriLytics platform is a mass spectrometry instrument that will support complex biotherapeutics development.

September 29, 2021

Alternatives to animal testing and in-vivo assays are occurring as a result of recent scientific advances.

September 13, 2021

Boehringer Ingelheim and Twist Bioscience will use Twist’s antibody libraries to discover therapeutic antibody candidates.

September 10, 2021

Vector Laboratories has completed a $124 million cash buyout backed by Thompson Street Capital Partners and will begin an acquisition strategy to expand protein detection capabilities.

September 03, 2021

The US government has granted Thermo Fisher Scientific a $192.5 million contract that the company will use to expand domestic manufacturing for pipette tips.